PFE Pfizer Inc.
$29.36
Pfizer Inc. (PFE) is expected to report earnings on February 2, 2027, before the market open. The consensus earnings estimate is $0.69 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -4.3% since its last earnings release on November 3, 2026.
Pfizer Beat Expectations, Raises Guidance
Tuesday, November 3, 2026 · 6:45 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 2
Tuesday · 6:45 AM ET
Earnings Whisper
-
vs $0.69
Rev est $17.41B
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$29.82
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About Pfizer Inc.
Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments: Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare.
Sector
Healthcare
Industry
Drug Manufacturers / Major
Held By 13 ETFs, by dollar flow
- BUZZ Vaneck Social Sentiment ETF
- XLG Invesco S&P 500 Top 50 ETF
- OEF iShares S&P 100 ETF
- IOO iShares Global 100 ETF
- MOAT VanEck Morningstar Wide Moat ETF
- DVY iShares Select Dividend ETF
- IYH iShares U.S. Healthcare ETF
- XLV Health Care Select Sector SPDR Fund
- IXJ iShares Global Healthcare ETF
- BMED iShares Health Innovation Active ETF
- PPH VanEck Pharmaceutical ETF
- XPH SPDR S&P Pharmaceuticals ETF
- IHE iShares U.S. Pharmaceuticals ETF
Charts powered in part by Lightweight Charts™ by TradingView.